348 related articles for article (PubMed ID: 35487087)
41. MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A.
Ruiz-Romeu E; Ferran M; Giménez-Arnau A; Bugara B; Lipert B; Jura J; Florencia EF; Prens EP; Celada A; Pujol RM; Santamaria-Babí LF
J Invest Dermatol; 2016 Aug; 136(8):1599-1607. PubMed ID: 27180111
[TBL] [Abstract][Full Text] [Related]
42. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
43. Perillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathways.
Sudha Yalamarthi S; Puppala ER; Abubakar M; Saha P; Challa VS; Np S; Usn M; Gangasani JK; Naidu VGM
Int Immunopharmacol; 2022 Feb; 103():108436. PubMed ID: 34929480
[TBL] [Abstract][Full Text] [Related]
44. MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.
Monin L; Gudjonsson JE; Childs EE; Amatya N; Xing X; Verma AH; Coleman BM; Garg AV; Killeen M; Mathers A; Ward NL; Gaffen SL
J Immunol; 2017 Jan; 198(2):767-775. PubMed ID: 27920272
[TBL] [Abstract][Full Text] [Related]
45. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
Zhao J; Xie X; Di T; Liu Y; Qi C; Chen Z; Li P; Wang Y
Int Immunopharmacol; 2021 May; 94():107229. PubMed ID: 33611057
[TBL] [Abstract][Full Text] [Related]
46. Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response.
Jiang Y; Lu S; Lai Y; Wang L
J Dermatol Sci; 2023 Jun; 110(3):89-98. PubMed ID: 37173222
[TBL] [Abstract][Full Text] [Related]
47. Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis.
Xu R; Li X; Huang X; Lin Z; Xiong Y; Chen X; Chu C; Han J; Wang F
J Dermatol Sci; 2023 Apr; 110(1):10-18. PubMed ID: 37024314
[TBL] [Abstract][Full Text] [Related]
48. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes.
Sun S; Zhang X; Xu M; Zhang F; Tian F; Cui J; Xia Y; Liang C; Zhou S; Wei H; Zhao H; Wu G; Xu B; Liu X; Yang G; Wang Q; Zhang L; Gong Y; Shao C; Zou Y
Cell Death Dis; 2019 Mar; 10(4):274. PubMed ID: 30894513
[TBL] [Abstract][Full Text] [Related]
49. Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway.
Álvarez-Coiradas E; Munteanu CR; Díaz-Sáez L; Pazos A; Huber KVM; Loza MI; Domínguez E
Int Immunopharmacol; 2020 Dec; 89(Pt A):107026. PubMed ID: 33045560
[TBL] [Abstract][Full Text] [Related]
50. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
[TBL] [Abstract][Full Text] [Related]
51. Targeting Nrf2 with 3 H-1,2-dithiole-3-thione to moderate OXPHOS-driven oxidative stress attenuates IL-17A-induced psoriasis.
Liu CT; Yen JJ; Brown DA; Song YC; Chu MY; Hung YH; Tang YH; Wu PY; Yen HR
Biomed Pharmacother; 2023 Mar; 159():114294. PubMed ID: 36706632
[TBL] [Abstract][Full Text] [Related]
52. Anti-interleukin 33 treatment alleviates psoriatic dermatitis in mice induced imiquimod.
Fu D; Zheng S; Li J; Hu H; Wang Q; Fu X; Li M; Yan D; Yang Z; Tian Z; Song X
Int Immunopharmacol; 2023 Aug; 121():110480. PubMed ID: 37343370
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
Xu X; Prens E; Florencia E; Leenen P; Boon L; Asmawidjaja P; Mus AM; Lubberts E
Front Immunol; 2021; 12():719562. PubMed ID: 34616394
[TBL] [Abstract][Full Text] [Related]
54. Extracellular CIRP Upregulates Proinflammatory Cytokine Expression via the NF-kappaB and ERK1/2 Signaling Pathways in Psoriatic Keratinocytes.
Zhang X; Wang S; Wang W; Song L; Feng S; Wang J; Kang T; Yang P; Wang N; Yang P; Bai R; Shao Y; Zheng Y
Mediators Inflamm; 2022; 2022():5978271. PubMed ID: 36110097
[TBL] [Abstract][Full Text] [Related]
55. The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis.
Li HJ; Wu NL; Lee GA; Hung CF
Sci Rep; 2018 Apr; 8(1):6335. PubMed ID: 29679037
[TBL] [Abstract][Full Text] [Related]
56. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
[TBL] [Abstract][Full Text] [Related]
57. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells.
Nakamizo S; Honda T; Adachi A; Nagatake T; Kunisawa J; Kitoh A; Otsuka A; Dainichi T; Nomura T; Ginhoux F; Ikuta K; Egawa G; Kabashima K
Sci Rep; 2017 Oct; 7(1):14076. PubMed ID: 29074858
[TBL] [Abstract][Full Text] [Related]
58. IL-17A Promotes Psoriasis-Associated Keratinocyte Proliferation through ACT1-Dependent Activation of YAP-AREG Axis.
Yu Z; Yu Q; Xu H; Dai X; Yu Y; Cui L; Chen Y; Gu J; Zhang X; Guo C; Shi Y
J Invest Dermatol; 2022 Sep; 142(9):2343-2352. PubMed ID: 35304250
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice.
Kim HJ; Kim SH; Kim TG; Park JY; Lee M; Kim DS; Lee MG
Exp Dermatol; 2018 Feb; 27(2):191-195. PubMed ID: 29220875
[TBL] [Abstract][Full Text] [Related]
60. IL-17A-driven psoriasis is critically dependent on IL-36 signaling.
Fischer B; Kübelbeck T; Kolb A; Ringen J; Waisman A; Wittmann M; Karbach S; Kölsch SM; Kramer D
Front Immunol; 2023; 14():1256133. PubMed ID: 38162658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
